Burnout in US oncologists has increased over the past 10 years, according to results of 2 surveys. 1 Researchers compared results of a 2023 survey of 328 oncologists to results of a 2013 survey of ...

DNA testing may inform treatment decisions and predict outcomes of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.

States and the nation’s health industry were thrown into disarray after the Trump administration ordered that the government freeze nearly all federal grants at 5 pm ET on Tuesday.

(HealthDay News) — Young adults with cancer may have a higher risk of death if they live in historically redlined neighborhoods, according to a study published in Cancer.

The CIA's new assessment adds to the ongoing debate about the origins of COVID-19, but the exact cause is still uncertain.

Researchers, federal employees, and members of the public have voiced concerns about restrictions recently placed on federal ...

Neoadjuvant CRT plus sintilimab yielded a higher pCR rate than neoadjuvant chemo plus sintilimab in patients with locally ...

New research suggests that firstborn twins may have a greater risk of developing leukemia than second-born twins.

Incorporating mpMRI into initial staging before TURBT reduces the time to correct treatment for patients with MIBC.

A growing body of research suggests that exposure to PFAS, commonly called "forever chemicals," may increase a person's risk ...

The FDA has approved Enhertu (fam-trastuzumab deruxtecan-nxki) for HR-positive, HER2-low or HER2-ultralow metastatic breast cancer.